血管性血友病因子反映细菌易位、炎症与促凝失衡,并独立于门静脉高压严重程度预测肝硬化并发症
研究纳入225例肝静脉压力梯度≥10 mm Hg且无活动性细菌感染或肝细胞癌的肝硬化患者,发现血管性血友病因子(vWF)与细菌易位标志物、炎症指标及促凝失衡相关,且这些关联独立于肝静脉压力梯度。vWF可独立预测静脉曲张出血、需腹腔穿刺和细菌感染,基于vWF/CRP的分组能有效区分5年生存差与预后良好的患者。
要点
- vWF与细菌易位标志物LBP、炎症指标IL-6和CRP及促凝失衡(因子VIII/蛋白C比值)相关。
- vWF与上述指标的关联独立于肝静脉压力梯度。
- vWF每增加10%独立预测静脉曲张出血、需腹腔穿刺和细菌感染。
核心结论
- vWF不仅是门静脉高压的标志物,还独立与细菌易位、炎症和促凝失衡相关,这可能解释其与多数临床事件的非肝静脉压力梯度依赖性关联。
- 基于vWF/CRP的预后分组能有效区分5年生存差与预后良好的患者。
研究设计与样本
- 研究人群包括225例肝静脉压力梯度≥10 mm Hg、无活动性细菌感染或肝细胞癌的患者。
主要发现
- vWF与细菌易位标志物脂多糖结合蛋白(LBP)相关(ρ=0.201;P=0.021)。
- vWF与炎症标志物白细胞介素6(IL-6;ρ=0.426;P<0.001)和C反应蛋白(CRP;ρ=0.249;P<0.001)相关。
- vWF与促凝失衡(因子VIII/蛋白C比值;ρ=0.507;P<0.001)相关。
- vWF与上述参数的关联独立于肝静脉压力梯度。
- vWF每增加10%独立预测静脉曲张出血(HR:1.08 [95%CI:1.01-1.16];P=0.023)、需腹腔穿刺(HR:1.05 [95%CI:1.01-1.1];P=0.023)和细菌感染(HR:1.04 [95%CI:1-1.09];P=0.04),包括自发性细菌性腹膜炎(HR:1.09 [95%CI:0.999-1.18];P=0.053)呈趋势水平。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Elevated plasma von Willebrand factor antigen (vWF) has been shown to indicate the presence of clinically significant portal hypertension, and thus, predicts the development of clinical events in patients with cirrhosis. AIM: To investigate the impact of bacterial translocation and inflammation on vWF, as well as the association between vWF and procoagulant imbalance. Moreover, we assessed whether vWF predicts complications of cirrhosis, independent of the severity of portal hypertension. METHODS: Our study population comprised 225 patients with hepatic venous pressure gradient (HVPG) ≥ 10 mm Hg without active bacterial infections or hepatocellular carcinoma. RESULTS: vWF correlated with markers of bacterial translocation (lipopolysaccharide-binding protein [LBP; ρ = 0.201; P = 0.021]), inflammation (interleukin 6 [IL-6; ρ = 0.426; P < 0.001] and C-reactive protein [CRP; ρ = 0.249; P < 0.001]), and procoagulant imbalance (factor VIII/protein C ratio; ρ = 0.507; P < 0.001). Importantly, the associations between vWF and these parameters were independent of HVPG. Moreover, vWF (per 10%) independently predicted variceal bleeding (hazard ratio [HR]: 1.08 [95% confidence interval (95% CI): 1.01-1.16]; P = 0.023), requirement of paracentesis (HR: 1.05 [95% CI: 1.01-1.1]; P = 0.023) and bacterial infections (HR: 1.04 [95% CI: 1-1.09]; P = 0.04) including spontaneous bacterial peritonitis (HR: 1.09 [95% CI: 0.999-1.18]; P = 0.053) on a trend-wise level. After backward elimination, vWF (HR: 1.05 [95% CI: 1.02-1.08]; P = 0.003) and CRP (per 10 mg/L; HR: 1.53 [95% CI: 1.14-2.05]; P = 0.005) remained in the final model for transplant-free mortality. Finally, the independent prognostic value of vWF/CRP groups for mortality was confirmed by competing risk analysis. CONCLUSION: Our results demonstrate that vWF is not only a marker of portal hypertension but also independently linked to bacterial translocation, inflammation and procoagulant imbalance, which might explain its HVPG-independent association with most clinical events. Prognostic groups based on vWF/CRP efficiently discriminate between patients with a poor 5-year survival and patients with a favourable prognosis.
引用
- Mandorfer M, Schwabl P, Paternostro R, et al. Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity. Aliment Pharmacol Ther. 2018. PMID: 29377193. doi:10.1111/apt.14522
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。